Mark Samuels

Mark Samuels is the chief executive of the British Generic Manufacturers Association, where he advocates for the generic drug industry in the UK. He has expressed concerns about the potential impact of US tariffs on pharmaceuticals, stating that the costs of such tariffs would be difficult to absorb due to the already constrained pricing in a fiercely competitive market, which could lead to increased shortages of essential medications.